Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Li S, Liu Z, Jiao X, Gu J, Liu Z, Meng L, Li W, Zhang T, Liu J, Chai D, Liu J, Yang Z, Liu Y, Jiao R, Li X, Zhou H, Zhang Y.
Li S, et al. Among authors: jiao r.
Biochem Pharmacol. 2024 Jul;225:116282. doi: 10.1016/j.bcp.2024.116282. Epub 2024 May 16.
Biochem Pharmacol. 2024.
PMID: 38762147